Home » AKORN, INC. AND GENERAMEDIX SIGN COMMERCIAL MANUFACTURING SUPPLY AGREEMENT
AKORN, INC. AND GENERAMEDIX SIGN COMMERCIAL MANUFACTURING SUPPLY AGREEMENT
Akorn, Inc. announced that it has signed a Commercial Manufacturing Supply Agreement with GeneraMedix Inc., a privately held pharmaceutical company that develops, markets and sells generic injectable pharmaceutical products. Under the terms
of the Agreement, Akorn will manufacture injectable products in finished dosage
form for GeneraMedix, who will market these products in the GeneraMedix label.
The Agreement includes products currently available from Akorn, as well as select
injectable products from the Akorn internal product development pipeline.
BioSpace
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct